ArticleExperimental and therapeutic medicine2022
Buschke-Löwenstein tumors: A series of 7 case reports.
Article in Experimental and therapeutic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 11 citations in OpenAlex.
- MRI assessment of locoregional extent in a Buschke-Löwenstein tumor with histopathologically confirmed malignant transformation: A case report.Radiology case reports · 2026Article
- Surgical excision for giant condyloma acuminatum (Buschke-Löwenstein tumor): A case report.Case reports in women's health · 2026Article
- Buschke-Lowenstein tumour managed by wide excision and V-Y flap reconstruction: report of two cases.Journal of surgical case reports · 2026Article
- A Two-Decade Journey of Buschke-Löwenstein Tumor Without Malignant Transformation: Clinical Insights and Management.Cureus · 2026Article
- Buschke-Löwenstein Tumor of the Vulva: Clinical Neglect, Molecular Continuum, and Pathogenetic Insights.Cureus · 2026Article
- Case Report: Definitive radiotherapy for inoperable anal Buschke-Löwenstein tumors: two cases with literature review.Frontiers in oncology · 2026Article
- Rapidly Progressive Perianal Giant Condyloma in an Immunocompetent Adolescent: An Unusual Abuse-Associated Case.Clinical, cosmetic and investigational dermatology · 2026Article
- Unmasking the Giant Condyloma: A Case Report and Literature Review of Buschke-Löwenstein Tumor.Cureus · 2025Article
- Buschke-Löwenstein Tumor: An Unusual Therapeutic Approach.GE Portuguese journal of gastroenterology · 2025Article
- Fine scalpel surgery: preserving the dartos muscle in a patient with scrotal and perigenital giant Buschke-Löwenstein tumors.Wiener medizinische Wochenschrift (1946) · 2024Article
- Clinicopathological Findings and Comprehensive Review of Buschke-Lowenstein Tumors Based on a Case Study.Journal of personalized medicine · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant condyloma acuminatum (GCA), or Buschke-Löwenstein tumor (BLT), represents an infrequent sexually transmitted disease (STD), caused by human papillomavirus (HPV), especially genotype 6 or 11. There are numerous risk factors for HPV, such as multiple sexual partners, homosexuality, prostitution, chronic genital infections, as well as the lack of proper hygiene. HPV infection is a field infection, where large areas of cells at a tissue surface are affected by the HPV virus; therefore, once the GCA is excised, treatment of the whole affected genital area needs to be undertaken. The treatment is classified into topical therapy (podophyllin, 5-FU, radiotherapy, topical photodynamic therapy), excisional therapy (CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.